Current view on osteogenic differentiation potential of mesenchymal stromal cells derived from placental tissues

Stem Cell Reviews and Reports

Volumn 11, Issue 4, 2015, Pages 570-585

  Kmiecik, Gabriela ^a   Spoldi, Valentina ^a   Silini, Antonietta ^a   Parolini, Ornella ^a  

^a Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

Author keywords

Amnioticmembrane; Chorionicmembrane; Decidua; Differentiation; Human placenta; Mesenchymal stromal cells (MSC); Osteogenesis; Umbilical cord; Wharton s jelly

Indexed keywords

BONE DEVELOPMENT; CELL DIFFERENTIATION; CERAMICS; CHEMISTRY; CYTOLOGY; FEMALE; HUMAN; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PLACENTA; PREGNANCY; PROCEDURES; TISSUE ENGINEERING; TISSUE SCAFFOLD;

CELL DIFFERENTIATION; CERAMICS; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PLACENTA; PREGNANCY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84943364366     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-014-9569-1     Document Type: Article

References (191)

1. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., & Frolova, G. P. (1968). Heterotopic of bone marrow. analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 6(2), 230–47
2. Mizuno, H., Tobita, M., & Uysal, A. C. (2012). Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells, 30(5), 804–10
3. Bourin, P., Bunnell, B. A., Casteilla, L., Dominici, M., Katz, A. J., March, K. L., et al. (2013). Stromal cells from the adipose tissuederived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the international federation for adipose therapeutics and science (IFATS) and the international society for cellular therapy (ISCT). Cytotherapy, 15(6), 641–8
4. Flynn, A., Barry, F., & O’Brien, T. (2007). UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy, 9(8), 717–26
5. Parolini, O., Alviano, F., Bagnara, G. P., Bilic, G., Buhring, H. J., Evangelista, M., et al. (2008). Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells, 26(2), 300–11
6. Huang, Y. C., Parolini, O., La Rocca, G., & Deng, L. (2012). Umbilical cord versus bone marrow-derived mesenchymal stromal cells. Stem Cells and Development, 21(15), 2900–3
7. Corrao, S., La Rocca, G., Lo Iacono, M., Corsello, T., Farina, F., & Anzalone, R. (2013). Umbilical cord revisited: fromWharton’s jelly myofibroblasts to mesenchymal stem cells. Histology and Histopathology, 28(10), 1235–44
8. Macias, M. I., Grande, J., Moreno, A., Dominguez, I., Bornstein, R., & Flores, A. I. (2010). Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. American Journal of Obstetrics and Gynecology, 203(5), 495 e9–495 e23
9. Can, A., & Karahuseyinoglu, S. (2007). Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells, 25(11), 2886–95
10. Soncini, M., Vertua, E., Gibelli, L., Zorzi, F., Denegri, M., Albertini, A., et al. (2007). Isolation and characterization of mesenchymal cells from human fetal membranes. Journal of Tissue Engineering and Regenerative Medicine, 1(4), 296–305
11. Bernardo, M. E., Emons, J. A., Karperien, M., Nauta, A. J., Willemze, R., Roelofs, H., et al. (2007). Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connective Tissue Research, 48(3), 132–40
12. Manuelpillai, U., Moodley, Y., Borlongan, C. V., & Parolini, O. (2011). Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta, 32(Suppl 4), S320–5
13. Insausti, C. L., Blanquer, M., Garcia-Hernandez, A. M., Castellanos, G., & Moraleda, J. M. (2014). Amniotic membranederived stem cells: immunomodulatory properties and potential clinical application. Stem Cells Cloning, 7, 53–63
14. La Rocca, G., Corrao, S., Lo Iacono, M., Corsello, T., Farina, F., & Anzalone, R. (2012). Novel immunomodulatory markers expressed by human WJ-MSC: an updated review in regenerative and reparative medicine. The Open Tissue Engineering and Regenerative Medicine Journal, 5(1), 50–58
15. Leyva-Leyva, M., Barrera, L., Lopez-Camarillo, C., Arriaga- Pizano, L., Orozco-Hoyuela, G., Carrillo-Casas, E. M., et al. (2013). Characterization of mesenchymal stem cell subpopulations from human amniotic membrane with dissimilar osteoblastic potential. Stem Cells and Development, 22(8), 1275–87
16. Jiang, G., Di Bernardo, J., Delong, C. J., Monteiro da Rocha, A., O’Shea, K. S., & Kunisaki, S. M. (2014). Induced pluripotent stem cells from human placental chorion for perinatal tissue engineering applications. Tissue Engineering. Part C, Methods, 20, 731–40
17. Jo, C. H., Kim, O. S., Park, E. Y., Kim, B. J., Lee, J. H., Kang, S. B., et al. (2008). Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell and Tissue Research, 334(3), 423–33
18. Portmann-Lanz, C. B., Schoeberlein, A., Huber, A., Sager, R., Malek, A., Holzgreve, W., et al. (2006). Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. American Journal of Obstetrics and Gynecology, 194(3), 664–73
19. Paldino, E., Cenciarelli, C., Giampaolo, A., Milazzo, L., Pescatori, M., Hassan, H. J., et al. (2014). Induction of dopaminergic neurons from human Wharton’s jelly mesenchymal stem cell by forskolin. Journal of Cellular Physiology, 229(2), 232–44
20. Kim, M. J., Shin, K. S., Jeon, J. H., Lee, D. R., Shim, S. H., Kim, J. K., et al. (2011). Human chorionic-plate-derivedmesenchymal stem cells and Wharton’s jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells. Cell and Tissue Research, 346(1), 53–64
21. Weiss, M. L., Anderson, C., Medicetty, S., Seshareddy, K. B., Weiss, R. J., VanderWerff, I., et al. (2008). Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells, 26(11), 2865–74
22. Uccelli, A., Moretta, L., & Pistoia, V. (2006). Immunoregulatory function of mesenchymal stem cells. European Journal of Immunology, 36(10), 2566–73
23. Eliopoulos, N., Stagg, J., Lejeune, L., Pommey, S., & Galipeau, J. (2005). Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood, 106(13), 4057–65
24. Parolini, O., Alviano, F., Bergwerf, I., Boraschi, D., De Bari, C., De Waele, P., et al. (2010). Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells and Development, 19(2), 143–54
25. Bailo, M., Soncini, M., Vertua, E., Signoroni, P. B., Sanzone, S., Lombardi, G., et al. (2004). Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation, 78(10), 1439–48
26. Magatti, M., De Munari, S., Vertua, E., Gibelli, L., Wengler, G. S., & Parolini, O. (2008). Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells, 26(1), 182–92
27. Magatti, M., De Munari, S., Vertua, E., Nassauto, C., Albertini, A., Wengler, G. S., et al. (2009). Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplantation, 18(8), 899–914
28. Magatti, M., Caruso, M., De Munari, S., Vertua, E., De, D., Manuelpillai, U., et al. (2014). Human amniotic membranederived mesenchymal and epithelial cells exert different effects on monocyte-derived dendritic cell differentiation and function. Cell Transplant.
29. Lee, J.M., Jung, J., Lee, H. J., Jeong, S. J., Cho, K. J., Hwang, S.G., et al. (2012). Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stemcells. International Immunopharmacology, 13(2), 219–24
30. Kim, D.W., Staples, M., Shinozuka, K., Pantcheva, P., Kang, S. D., & Borlongan, C. V. (2013). Wharton’s jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. International Journal of Molecular Sciences, 14(6), 11692–712
31. Kanematsu, D., Shofuda, T., Yamamoto, A., Ban, C., Ueda, T., Yamasaki, M., et al. (2011). Isolation and cellular properties of mesenchymal cells derived from the decidua of human term placenta. Differentiation, 82(2), 77–88
32. Rossi, D., Pianta, S., Magatti, M., Sedlmayr, P., & Parolini, O. (2012). Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS ONE, 7(10), e46956
33. Silini, A., Parolini, O., Huppertz, B., & Lang, I. (2013). Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies. Current Stem Cell Research & Therapy, 8(1), 6–14
34. Battula, V. L., Bareiss, P. M., Treml, S., Conrad, S., Albert, I., Hojak, S., et al. (2007). Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation, 75(4), 279–91
35. Battula, V. L., Treml, S., Abele, H., & Buhring, H. J. (2008). Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation, 76(4), 326–36
36. Bacenkova, D., Rosocha, J., Tothova, T., Rosocha, L., & Sarissky, M. (2011). Isolation and basic characterization of human term amnion and chorion mesenchymal stromal cells. Cytotherapy, 13(9), 1047–56
37. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C., & Deliliers, G. L. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Experimental Hematology, 30(7), 783–91
38. Kobayashi, M., Yakuwa, T., Sasaki, K., Sato, K., Kikuchi, A., Kamo, I., et al. (2008). Multilineage potential of side population cells fromhuman amnionmesenchymal layer. Cell Transplantation, 17(3), 291–301
39. Yang, Z. X., Han, Z. B., Ji, Y. R., Wang, Y. W., Liang, L., Chi, Y., et al. (2013). CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS ONE, 8(3), e59354
40. Pilz, G. A., Ulrich, C., Ruh, M., Abele, H., Schafer, R., Kluba, T., et al. (2011). Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrowderived mesenchymal stromal cells. Stem Cells and Development, 20(4), 635–46
41. Ulrich, C., Rolauffs, B., Abele, H., Bonin, M., Nieselt, K., Hart, M. L., et al. (2013). Low osteogenic differentiation potential of placenta-derived mesenchymal stromal cells correlates with low expression of the transcription factors Runx2 and Twist2. Stem Cells and Development, 22(21), 2859–72
42. Heng, B. C., Cao, T., Stanton, L. W., Robson, P., & Olsen, B. (2004). Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. Journal of Bone and Mineral Research, 19(9), 1379–94
43. Lindenmair, A., Hatlapatka, T., Kollwig, G., Hennerbichler, S., Gabriel, C., Wolbank, S., et al. (2012). Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. Cells, 1(4), 1061–88
44. Alviano, F., Fossati, V., Marchionni, C., Arpinati, M., Bonsi, L., Franchina, M., et al. (2007). Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Developmental Biology, 7, 11
45. Tang, M., Weir, M. D., & Xu, H. H. (2012). Mannitol-containing macroporous calcium phosphate cement encapsulating human umbilical cord stem cells. Journal of Tissue Engineering and Regenerative Medicine, 6(3), 214–24
46. Chen, W., Zhou, H., Weir, M. D., Bao, C., & Xu, H. H. (2012). Umbilical cord stem cells released from alginate-fibrin microbeads inside macroporous and biofunctionalized calcium phosphate cement for bone regeneration. Acta Biomaterialia, 8(6), 2297–306
47. Nekanti, U., Rao, V. B., Bahirvani, A. G., Jan, M., Totey, S., & Ta, M. (2010). Long-term expansion and pluripotent marker array analysis of Wharton’s jelly-derived mesenchymal stem cells. Stem Cells and Development, 19(1), 117–30
48. Cavallo, C., Cuomo, C., Fantini, S., Ricci, F., Tazzari, P. L., Lucarelli, E., et al. (2011). Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. Journal of Cellular Biochemistry, 112(5), 1418–30
49. Amable, P. R., Teixeira, M. V., Carias, R. B., Granjeiro, J. M., & Borojevic, R. (2014). Mesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasmasupplemented media. PLoS ONE, 9(8), e104662
50. Zeddou, M., Briquet, A., Relic, B., Josse, C., Malaise, M. G., Gothot, A., et al. (2010). The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biology International, 34(7), 693–701
51. Capelli, C., Gotti, E., Morigi, M., Rota, C., Weng, L., Dazzi, F., et al. (2011). Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy, 13(7), 786–801
52. Marmotti, A., Mattia, S., Bruzzone, M., Buttiglieri, S., Risso, A., Bonasia, D. E., et al. (2012). Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study. Stem Cells International, 2012, 326813
53. Poloni, A., Maurizi, G., Serrani, F., Mancini, S., Discepoli, G., Tranquilli, A. L., et al. (2012). Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate. Cell Proliferation, 45(1), 66–75
54. Martins, J. P., Santos, J. M., Almeida, J. M., Filipe, M. A., de Almeida,M. V., Almeida, S. C., et al. (2014). Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data. Stem Cell Research & Therapy, 5(1), 9
55. Baba, K., Yamazaki, Y., Ikemoto, S., Aoyagi, K., Takeda, A., & Uchinuma, E. (2012). Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived autoserum. Journal of Cranio-Maxillo-Facial Surgery, 40(8), 768–72
56. Baba, K., Yamazaki, Y., Ishiguro, M., Kumazawa, K., Aoyagi, K., Ikemoto, S., et al. (2013). Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived fibrin: a preliminary study. Journal of Cranio- Maxillo-Facial Surgery, 41(8), 775–82
57. Hou, T., Xu, J., Wu, X., Xie, Z., Luo, F., Zhang, Z., et al. (2009). Umbilical cord Wharton’s jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering. Tissue Engineering Part A, 15(9), 2325–34
58. Raynaud, C. M., Maleki, M., Lis, R., Ahmed, B., Al-Azwani, I., Malek, J., et al. (2012). Comprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation. Stem Cells International, 2012, 658356
59. Sanvoranart, T., Supokawej, A., Kheolamai, P., U-pratya, Y., Klincumhom, N., Manochantr, S., et al. (2014). Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues. Biochemical and Biophysical Research Communications, 447(4), 580–5
60. Wu, W., Ye, Z., Zhou, Y., & Tan, W. S. (2011). AICAR, a small chemical molecule, primes osteogenic differentiation of adult mesenchymal stem cells. International Journal of Artificial Organs, 34(12), 1128–36
61. Raicevic, G., Najar, M., Pieters, K., De Bruyn, C., Meuleman, N., Bron, D., et al. (2012). Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. Tissue Engineering Part A, 18(13–14), 1410–8
62. Wiesmann, A., Buhring, H. J., Mentrup, C., & Wiesmann, H. P. (2006). Decreased CD90 expression in human mesenchymal stem cells by applying mechanical stimulation. Head & Face Medicine, 2, 8
63. Kang, M.N., Yoon, H. H., Seo, Y. K., & Park, J. K. (2012). Effect of mechanical stimulation on the differentiation of cord stem cells. Connective Tissue Research, 53(2), 149–59
64. Bosch, J., Houben, A. P., Radke, T. F., Stapelkamp, D., Bunemann, E., Balan, P., et al. (2012). Distinct differentiation potential of “MSC” derived from cord blood and umbilical cord: are cordderived cells true mesenchymal stromal cells? Stem Cells and Development, 21(11), 1977–88
65. Sudo, K., Kanno, M., Miharada, K., Ogawa, S., Hiroyama, T., Saijo, K., et al. (2007).Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations. Stem Cells, 25(7), 1610–7
66. Zhou, J., Xu, C., Wu, G., Cao, X., Zhang, L., Zhai, Z., et al. (2011). In vitro generation of osteochondral differentiation of human marrow mesenchymal stem cells in novel collagen-hydroxyapatite layered scaffolds. Acta Biomaterialia, 7(11), 3999–4006
67. Reichert, J. C., Heymer, A., Berner, A., Eulert, J., & Noth, U. (2009). Fabrication of polycaprolactone collagen hydrogel constructs seeded with mesenchymal stem cells for bone regeneration. Biomedical Materials, 4(6), 065001
68. Schneider, R. K., Puellen, A., Kramann, R., Raupach, K., Bornemann, J., Knuechel, R., et al. (2010). The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials, 31(3), 467–80
69. Penolazzi, L., Mazzitelli, S., Vecchiatini, R., Torreggiani, E., Lambertini, E., Johnson, S., et al. (2012). Human mesenchymal stem cells seeded on extracellular matrix-scaffold: viability and osteogenic potential. Journal of Cellular Physiology, 227(2), 857–66
70. Rodriguez-Fuentes, N., Rodriguez-Hernandez, A. G., Enriquez-Jimenez, J., Alcantara-Quintana, L. E., Fuentes- Mera, L., Pina-Barba, M. C., et al. (2013). Nukbone(R) promotes proliferation and osteoblastic differentiation of mesenchymal stem cells from human amniotic membrane. Biochemical and Biophysical Research Communications, 434(3), 676–80
71. Mohr, S., Portmann-Lanz, C. B., Schoeberlein, A., Sager, R., & Surbek,D.V. (2010). Generation of an osteogenic graft fromhuman placenta and placenta-derived mesenchymal stem cells. Reproductive Sciences, 17(11), 1006–15
72. Niknejad, H., Peirovi, H., Jorjani, M., Ahmadiani, A., Ghanavi, J., & Seifalian, A.M. (2008). Properties of the amniotic membrane for potential use in tissue engineering. European Cells & Materials, 15, 88–99
73. Parolini, O., Soncini, M., Evangelista, M., & Schmidt, D. (2009). Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regenerative Medicine, 4(2), 275–91
74. Lindenmair, A., Wolbank, S., Stadler, G., Meinl, A., Peterbauer- Scherb, A., Eibl, J., et al. (2010). Osteogenic differentiation of intact human amniotic membrane. Biomaterials, 31(33), 8659–65
75. Gauthaman, K., Venugopal, J. R., Yee, F. C., Biswas, A., Ramakrishna, S., & Bongso, A. (2011). Osteogenic differentiation of human Wharton’s jelly stem cells on nanofibrous substrates in vitro. Tissue Engineering Part A, 17(1–2), 71–81
76. Zhang, Z. Y., Teoh, S. H., Chong, M. S., Schantz, J. T., Fisk, N.M., Choolani, M. A., et al. (2009). Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells, 27(1), 126–37
77. Zhang, D., Tong, A., Zhou, L., Fang, F., & Guo, G. (2012). Osteogenic differentiation of human placenta-derived mesenchymal stem cells (PMSCs) on electrospun nanofiber meshes. Cytotechnology, 64(6), 701–10
78. Wang, L., Dormer, N. H., Bonewald, L. F., & Detamore, M. S. (2010). Osteogenic differentiation of human umbilical cord mesenchymal stromal cells in polyglycolic acid scaffolds. Tissue Engineering Part A, 16(6), 1937–48
79. Wang, F., Zhang, Y. C., Zhou, H., Guo, Y. C., & Su, X. X. (2014). Evaluation of in vitro and in vivo osteogenic differentiation of nano-hydroxyapatite/chitosan/poly(lactide-coglycolide) scaffolds with human umbilical cord mesenchymal stem cells. Journal of Biomedical Materials Research. Part A, 102(3), 760–8
80. Bertoldi, S., Fare, S., Denegri, M., Rossi, D., Haugen, H. J., Parolini, O., et al. (2010). Ability of polyurethane foams to support placenta-derived cell adhesion and osteogenic differentiation: preliminary results. Journal of Materials Science Materials in Medicine, 21(3), 1005–11
81. Dormer, N. H., Singh, M., Wang, L., Berkland, C. J., & Detamore, M. S. (2010). Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals. Annals of Biomedical Engineering, 38(6), 2167–82
82. Wang, L., Zhao, L., & Detamore, M. S. (2011). Human umbilical cord mesenchymal stromal cells in a sandwich approach for osteochondral tissue engineering. Journal of Tissue Engineering and Regenerative Medicine, 5(9), 712–21
83. Wang, L., Singh, M., Bonewald, L. F., & Detamore, M. S. (2009). Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. Journal of Tissue Engineering and Regenerative Medicine, 3(5), 398–404
84. Thein-Han, W., & Xu, H. H. (2011). Collagen-calcium phosphate cement scaffolds seeded with umbilical cord stem cells for bone tissue engineering. Tissue Engineering Part A, 17(23–24), 2943–54
85. TheinHan, W., Weir, M. D., Simon, C. G., & Xu, H. H. (2013). Non-rigid calcium phosphate cement containing hydrogel microbeads and absorbable fibres seeded with umbilical cord stem cells for bone engineering. Journal of Tissue Engineering and Regenerative Medicine, 7(10), 777–87
86. Xu, H. H., Zhao, L., Detamore, M. S., Takagi, S., & Chow, L. C. (2010). Umbilical cord stem cell seeding on fast-resorbable calcium phosphate bone cement. Tissue Engineering Part A, 16(9), 2743–53
87. Zhou, H., Weir, M. D., & Xu, H. H. (2011). Effect of cell seeding density on proliferation and osteodifferentiation of umbilical cord stem cells on calcium phosphate cement-fiber scaffold. Tissue Engineering Part A, 17(21–22), 2603–13
88. Xu, H. H., Zhao, L., & Weir, M. D. (2010). Stem cell-calcium phosphate constructs for bone engineering. Journal of Dental Research, 89(12), 1482–8
89. Zhao, L., Weir, M. D., & Xu, H. H. (2010). Human umbilical cord stem cell encapsulation in calcium phosphate scaffolds for bone engineering. Biomaterials, 31(14), 3848–57
90. Zhao, L., Tang, M., Weir, M.D., Detamore, M.S., & Xu, H. H. (2011). Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold. Tissue Engineering Part A, 17(7–8), 969–79
91. Zhao, L., Weir, M. D., & Xu, H. H. (2010). An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials, 31(25), 6502–10
92. Zhou, H., & Xu, H. H. (2011). The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering. Biomaterials, 32(30), 7503–13
93. Bao, C., Chen, W., Weir, M.D., Thein-Han, W., & Xu, H.H. (2011). Effects of electrospun submicron fibers in calcium phosphate cement scaffold on mechanical properties and osteogenic differentiation of umbilical cord stem cells. Acta Biomaterialia, 7(11), 4037–44
94. Thein-Han, W., Liu, J., & Xu, H. H. (2012). Calcium phosphate cement with biofunctional agents and stem cell seeding for dental and craniofacial bone repair. Dental Materials, 28(10), 1059–70
95. Zhou, H., Chen, W., Weir, M. D., & Xu, H. H. (2012). Biofunctionalized calcium phosphate cement to enhance the attachment and osteodifferentiation of stem cells released from fastdegradable alginate-fibrin microbeads. Tissue Engineering Part A, 18(15–16), 1583–95
96. Diao, Y., Ma, Q., Cui, F., & Zhong, Y. (2009). Human umbilical cord mesenchymal stem cells: osteogenesis in vivo as seed cells for bone tissue engineering. Journal of BiomedicalMaterials Research. Part A, 91(1), 123–31
97. Wang, B., Huang, S., Pan, L., & Jia, S. (2013). Enhancement of bone formation by genetically engineered human umbilical cord-derived mesenchymal stem cells expressing osterix. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 116(4), e221–9
98. Li, Y., Hou, R., Wang, Y., Lu, B., Zhang, J., Feng, X., et al. (2014). Fundamental study of application of umbilical cord mesenchymal stem cells to the periodontium to aid healing after autotransplantation of teeth. British Journal of Oral and Maxillofacial Surgery, 52(6), 501–6
99. Zhang, Y., Wu, C., Friis, T., & Xiao, Y. (2010). The osteogenic properties of CaP/silk composite scaffolds. Biomaterials, 31(10), 2848–56
100. Zong, C., Xue, D., Yuan, W., Wang, W., Shen, D., Tong, X., et al. (2010). Reconstruction of rat calvarial defects with human mesenchymal stem cells and osteoblast-like cells in poly-lactic-co-glycolic acid scaffolds. European Cells & Materials, 20, 109–20
101. Chiu, L. H., Lai, W. F., Chang, S. F., Wong, C. C., Fan, C. Y., Fang, C. L., et al. (2014). The effect of type II collagen on MSC osteogenic differentiation and bone defect repair. Biomaterials, 35(9), 2680–91
102. Jo, C. H., Yoon, P.W., Kim, H., Kang, K. S., & Yoon, K. S. (2013). Comparative evaluation of in vivo osteogenic differentiation of fetal and adult mesenchymal stem cell in rat critical-sized femoral defect model. Cell and Tissue Research, 353(1), 41–52
103. Kumar, S., & Ponnazhagan, S. (2012). Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect. Bone, 50(4), 1012–8
104. Fan, Z. X., Lu, Y., Deng, L., Li, X. Q., Zhi, W., Li-Ling, J., et al. (2012). Placenta- versus bone-marrow-derived mesenchymal cells for the repair of segmental bone defects in a rabbit model. FEBS Journal, 279(13), 2455–65
105. Reddy, S., Wasnik, S., Guha, A., Kumar, J. M., Sinha, A., & Singh, S. (2013). Evaluation of nano-biphasic calcium phosphate ceramics for bone tissue engineering applications: in vitro and preliminary in vivo studies. Journal of Biomaterials Applications, 27(5), 565–75
106. Yuan, W., Zong, C., Huang, Y., Gao, Y., Shi, D., Chen, C., et al. (2012). Biological, immunological and regenerative characteristics of placenta-derived mesenchymal stem cell isolated using a time-gradient attachment method. Stem Cell Research, 9(2), 110–23
107. Tran, T. C., Kimura, K., Nagano, M., Yamashita, T., Ohneda, K., Sugimori, H., et al. (2011). Identification of human placenta-derived mesenchymal stem cells involved in re-endothelialization. Journal of Cellular Physiology, 226(1), 224–35
108. Kuo, H. C., Chiu, C. C., Chang, W. C., Sheen, J.M., Ou, C.Y., Kuo, H. C., et al. (2011). Use of proteomic differential displays to assess functional discrepancies and adjustments of human bone marrowand Wharton jelly-derived mesenchymal stem cells. Journal of Proteome Research, 10(3), 1305–15
109. Chen, W., Liu, J., Manuchehrabadi, N., Weir, M. D., Zhu, Z., & Xu, H. H. (2013). Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects. Biomaterials, 34(38), 9917–25
110. Qu, Z., Guo, L., Fang, G., Cui, Z., Guo, S., & Liu, Y. (2012). Biological characteristics and effect of human umbilical cord mesenchymal stem cells (hUC-MSCs) grafting with blood plasma on bone regeneration in rats. Cell Biochemistry and Biophysics, 63(2), 171–81
111. Jones, G. N., Moschidou, D., Puga-Iglesias, T. I., Kuleszewicz, K., Vanleene, M., Shefelbine, S. J., et al. (2012). Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS ONE, 7(9), e43395
112. Jones, G. N., Moschidou, D., Abdulrazzak, H., Kalirai, B. S., Vanleene, M., Osatis, S., et al. (2013). Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta. Stem Cells and Development, 23(3), 262–76
113. Li, X., Ling, W., Pennisi, A., Wang, Y., Khan, S., Heidaran, M., et al. (2011). Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiplemyeloma in bone. Stem Cells, 29(2), 263–73
114. Bilic, G., Zeisberger, S. M., Mallik, A. S., Zimmermann, R., & Zisch, A. H. (2008). Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplantation, 17(8), 955–68
115. Kim, J., Kang, H.M., Kim, H., Kim, M.R., Kwon, H.C., Gye, M. C., et al. (2007). Ex vivo characteristics of human amniotic membranederived stem cells. Cloning and Stem Cells, 9(4), 581–94
116. Moon, J. H., Lee, J. R., Jee, B. C., Suh, C. S., Kim, S. H., Lim, H. J., et al. (2008). Successful vitrification of human amnion-derived mesenchymal stem cells. Human Reproduction, 23(8), 1760–70
117. Stadler, G., Hennerbichler, S., Lindenmair, A., Peterbauer, A., Hofer, K., van Griensven, M., et al. (2008). Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro. Cytotherapy, 10(7), 743–52
118. Diaz-Prado, S., Muinos-Lopez, E., Hermida-Gomez, T., Rendal- Vazquez, M. E., Fuentes-Boquete, I., de Toro, F. J., et al. (2010). Multilineage differentiation potential of cells isolated from the human amniotic membrane. Journal of Cellular Biochemistry, 111(4), 846–57
119. Jaramillo-Ferrada, P. A., Wolvetang, E. J., & Cooper-White, J. J. (2012). Differential mesengenic potential and expression of stem cell-fate modulators in mesenchymal stromal cells from human-term placenta and bone marrow. Journal of Cellular Physiology, 227(9), 3234–42
120. Fatimah, S. S., Tan, G. C., Chua, K., Fariha, M. M., Tan, A. E., & Hayati, A. R. (2013). Stemness and angiogenic gene expression changes of serial-passage human amnion mesenchymal cells. Microvascular Research, 86, 21–9
121. Tamagawa, T., Ishiwata, I., & Nakamura, Y. (2005). Differentiation of human amniotic membrane cells into osteoblasts in vitro. Human Cell, 18(4), 191–5
122. Wolbank, S., Stadler, G., Peterbauer, A., Gillich, A., Karbiener, M., Streubel, B., et al. (2009). Telomerase immortalized human amnion- and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics. Tissue Engineering Part A, 15(7), 1843–54
123. In ’t Anker, P. S., Scherjon, S. A., Kleijburgvan der Keur, C., de Groot-Swings, G. M., Claas, F. H., Fibbe, W. E., et al. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22(7), 1338–45
124. Igura, K., Zhang, X., Takahashi, K., Mitsuru, A., Yamaguchi, S., & Takashi, T. A. (2004). Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy, 6(6), 543–53
125. Wulf, G. G., Viereck, V., Hemmerlein, B., Haase, D., Vehmeyer, K., Pukrop, T., et al. (2004). Mesengenic progenitor cells derived from human placenta. Tissue Engineering, 10(7–8), 1136–47
126. Kadam, S., Muthyala, S., Nair, P., & Bhonde, R. (2010). Human placenta-derived mesenchymal stem cells and isletlike cell clusters generated from these cells as a novel source for stem cell therapy in diabetes. The Review of Diabetic Studies, 7(2), 168–82
127. Fariha, M. M., Chua, K. H., Tan, G. C., Tan, A. E., & Hayati, A. R. (2011). Human chorion-derived stem cells: changes in stem cell properties during serial passage. Cytotherapy, 13(5), 582–93
128. Koo, B.K., Park, I.Y., Kim, J., Kim, J.H., Kwon, A., Kim, M., et al. (2012). Isolation and characterization of chorionic mesenchymal stromal cells from human full term placenta. Journal of Korean Medical Science, 27(8), 857–63
129. Abumaree, M. H., Al Jumah, M. A., Kalionis, B., Jawdat, D., Al Khaldi, A., AlTalabani, A. A., et al. (2013). Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Reviews, 9(1), 16–31
130. Ha, J. W., Kim, J. A., & Ha, C. W. (2012). Do the fibroblasts contained in early passage MSC population adversely affect the characteristics of stem cell population obtained from human placenta? International Journal Stem Cells, 5(2), 89–95
131. Zhang, X., Soda, Y., Takahashi, K., Bai, Y., Mitsuru, A., Igura, K., et al. (2006). Successful immortalization of mesenchymal progenitor cells derived from human placenta and the differentiation abilities of immortalized cells. Biochemical and Biophysical Research Communications, 351(4), 853–9
132. Resca, E., Zavatti, M., Bertoni, L., Maraldi, T., De Biasi, S., Pisciotta, A., et al. (2013). Enrichment in c-Kit+ enhances mesodermal and neural differentiation of human chorionic placental cells. Placenta, 34(7), 526–35
133. Poloni, A., Rosini, V., Mondini, E., Maurizi, G., Mancini, S., Discepoli, G., et al. (2008). Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. Cytotherapy, 10(7), 690–7
134. Meraviglia, V., Vecellio, M., Grasselli, A., Baccarin, M., Farsetti, A., Capogrossi, M. C., et al. (2012). Human chorionic villus mesenchymal stromal cells reveal strong endothelial conversion properties. Differentiation, 83(5), 260–70
135. Sung, H. J., Hong, S. C., Yoo, J.H., Oh, J.H., Shin, H. J., Choi, I.Y., et al. (2010). Stemness evaluation of mesenchymal stem cells from placentas according to developmental stage: comparison to those from adult bone marrow. Journal of Korean Medical Science, 25(10), 1418–26
136. Hayati, A. R., Nur Fariha, M. M., Tan, G. C., Tan, A. E., & Chua, K. (2011). Potential of human decidua stem cells for angiogenesis and neurogenesis. Archives of Medical Research, 42(4), 291–300
137. Zhong, Z. N., Zhu, S. F., Yuan, A. D., Lu, G. H., He, Z. Y., Fa, Z. Q., et al. (2012). Potential of placenta-derived mesenchymal stem cells as seed cells for bone tissue engineering: preliminary study of osteoblastic differentiation and immunogenicity. Orthopedics, 35(9), 779–88
138. Dimitrov, R., Kyurkchiev, D., Timeva, T., Yunakova, M., Stamenova, M., Shterev, A., et al. (2010). First-trimester human decidua contains a population of mesenchymal stem cells. Fertility and Sterility, 93(1), 210–9
139. Fukuchi, Y., Nakajima, H., Sugiyama, D., Hirose, I., Kitamura, T., & Tsuji, K. (2004). Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells, 22(5), 649–58
140. Yen, B. L., Huang, H. I., Chien, C. C., Jui, H. Y., Ko, B. S., Yao, M., et al. (2005). Isolation of multipotent cells from human term placenta. Stem Cells, 23(1), 3–9
141. Musina, R. A., Bekchanova, E. S., Belyavskii, A. V., & Sukhikh, G. T. (2006). Differentiation potential of mesenchymal stem cells of different origin. Bulletin of Experimental Biology and Medicine, 141(1), 147–51
142. Jones, B. J., Brooke, G., Atkinson, K., & McTaggart, S. J. (2007). Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells. Placenta, 28(11–12), 1174–81
143. Li, D., Wang, G. Y., Dong, B. H., Zhang, Y. C., Wang, Y. X., & Sun, B. C. (2007). Biological characteristics of human placental mesenchymal stem cells and their proliferative response to various cytokines. Cells,Tissues,Organs, 186(3), 169–79
144. Barlow, S., Brooke, G., Chatterjee, K., Price, G., Pelekanos, R., Rossetti, T., et al. (2008). Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells and Development, 17(6), 1095–107
145. Ostanin, A. A., Petrovskiy, Y. L., Shevela, E. Y., Kurganova, E. V., Drobinskaja, A. N., Dobryakova, O. B., et al. (2008). A new approach to evaluation of osteogenic potential of mesenchymal stromal cells. Bulletin of Experimental Biology and Medicine, 146(4), 534–9
146. Montesinos, J. J., Flores-Figueroa, E., Castillo-Medina, S., Flores- Guzman, P., Hernandez-Estevez, E., Fajardo-Orduna, G., et al. (2009). Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy, 11(2), 163–76
147. Castrechini, N.M., Murthi, P., Gude, N.M., Erwich, J. J., Gronthos, S., Zannettino, A., et al. (2010). Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche. Placenta, 31(3), 203–12
148. Semenov, O. V., Koestenbauer, S., Riegel, M., Zech, N., Zimmermann, R., Zisch, A. H., et al. (2010). Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. American Journal of Obstetrics and Gynecology, 202(2), 193 e1–193 e13
149. Sun, N. Z., & Ji, H. (2012). In vitro differentiation of osteocytes and adipocytes from human placenta-derived cells. Journal of International Medical Research, 40(2), 761–7
150. Sabapathy, V., Ravi, S., Srivastava, V., Srivastava, A., & Kumar, S. (2012). Long-term cultured human term placenta-derived mesenchymal stem cells of maternal origin displays plasticity. Stem Cells International, 2012, 174328
151. Vellasamy, S., Sandrasaigaran, P., Vidyadaran, S., George, E., & Ramasamy, R. (2012). Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. World Journal Stem Cells, 4(6), 53–61
152. Ho, P. J., Yen, M. L., Tang, B. C., Chen, C. T., & Yen, B. L. (2013). H2O2 accumulationmediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells. Antioxidants and Redox Signaling, 18(15), 1895–905
153. GuillaumeGentil, O., Semenov, O. V., Zisch, A. H., Zimmermann, R., Voros, J., & Ehrbar, M. (2011). pH-controlled recovery of placenta-derived mesenchymal stem cell sheets. Biomaterials, 32(19), 4376–84
154. Zhu, Z., Liu, Z., Liu, J., Bi, M., Yang, T., & Wang, J. (2014). Proteomic profiling of human placenta-derived mesenchymal stem cells upon transforming LIM mineralization protein-1 stimulation. Cytotechnology. doi: 10.1007/s10616-013-3684-x.
155. Lu, L. L., Liu, Y. J., Yang, S. G., Zhao, Q. J., Wang, X., Gong, W., et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 91(8), 1017–26
156. Karahuseyinoglu, S., Cinar, O., Kilic, E., Kara, F., Akay, G. G., Demiralp, D. O., et al. (2007). Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells, 25(2), 319–31
157. Girdlestone, J., Limbani, V. A., Cutler, A. J., & Navarrete, C. V. (2009). Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy, 11(6), 738–48
158. La Rocca, G., Anzalone, R., Corrao, S., Magno, F., Loria, T., Lo Iacono, M., et al. (2009). Isolation and characterization of Oct-4+/ HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochemistry and Cell Biology, 131(2), 267–82
159. Penolazzi, L., Vecchiatini, R., Bignardi, S., Lambertini, E., Torreggiani, E., Canella, A., et al. (2009). Influence of obstetric factors on osteogenic potential of umbilical cordderived mesenchymal stem cells. Reproductive Biology and Endocrinology, 7, 106
160. Caballero, M., Reed, C. R., Madan, G., & van Aalst, J. A. (2010). Osteoinduction in umbilical cord- and palate periosteum-derived mesenchymal stem cells. Annals of Plastic Surgery, 64(5), 605–9
161. Hartmann, I., Hollweck, T., Haffner, S., Krebs, M., Meiser, B., Reichart, B., et al. (2010). Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. Journal of Immunological Methods, 363(1), 80–9
162. Hsieh, J. Y., Fu, Y. S., Chang, S. J., Tsuang, Y. H., & Wang, H. W. (2010). Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow andWharton’s jelly of umbilical cord. Stem Cells and Development, 19(12), 1895–910
163. Nekanti, U., Mohanty, L., Venugopal, P., Balasubramanian, S., Totey, S., & Ta, M. (2010). Optimization and scale-up of Wharton’s jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Research, 5(3), 244–54
164. Cheng, H., Qiu, L., Ma, J., Zhang, H., Cheng, M., Li, W., et al. (2011). Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts. Molecular Biology Reports, 38(8), 5161–8
165. Montanucci, P., Basta, G., Pescara, T., Pennoni, I., Di Giovanni, F., & Calafiore, R. (2011). New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly. Tissue Engineering Part A, 17(21–22), 2651–61
166. Tsagias, N., Koliakos, I., Karagiannis, V., Eleftheriadou, M., & Koliakos, G. G. (2011). Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Transfusion Medicine, 21(4), 253–61
167. Chen, H. C., Lee, Y. S., Sieber, M., Lu, H. T., Wei, P. C., Wang, C. N., et al. (2012). MicroRNA and messenger RNA analyses of mesenchymal stem cells derived from teeth and the Wharton jelly of umbilical cord. Stem Cells and Development, 21(6), 911–22
168. Gong, W., Han, Z., Zhao, H., Wang, Y., Wang, J., Zhong, J., et al. (2012). Banking human umbilical cord-derived mesenchymal stromal cells for clinical use. Cell Transplantation, 21(1), 207–16
169. Salehinejad, P., Alitheen, N. B., Nematollahi-Mahani, S. N., Ali, A. M., Omar, A. R., Janzamin, E., et al. (2012). Effect of culture media on expansion properties of human umbilical cord matrix-derived mesenchymal cells. Cytotherapy, 14(8), 948–53
170. Christodoulou, I., Kolisis, F. N., Papaevangeliou, D., & Zoumpourlis, V. (2013). Comparative evaluation of human mesenchymal stem cells of fetal (Wharton’s jelly) and adult (adipose tissue) Origin during prolonged in vitro expansion: considerations for cytotherapy. Stem Cells International, 2013, 246134
171. Corotchi, M. C., Popa, M. A., Remes, A., Sima, L. E., Gussi, I., & Lupu Plesu, M. (2013). Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton’s jelly-derived mesenchymal stem cells. Stem Cell Research & Therapy, 4(4), 81
172. Huang, S., Feng, C., Wu, Y., Yang, S., Ma, K., Wu, X., et al. (2013). Dissimilar characteristics of umbilical cord mesenchymal stem cells from donors of different ages. Cell and Tissue Banking, 14(4), 707–13
173. Kouroupis, D., Churchman, S. M., English, A., Emery, P., Giannoudis, P. V., McGonagle, D., et al. (2013). Assessment of umbilical cord tissue as a source of mesenchymal stem cell/endothelial cell mixtures for bone regeneration. Regenerative Medicine, 8(5), 569–81
174. La Rocca, G., Lo Iacono, M., Corsello, T., Corrao, S., Farina, F., & Anzalone, R. (2013). Human Wharton’s jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy. Current Stem Cell Research & Therapy, 8(1), 100–13
175. Patel, A. N., Vargas, V., Revello, P., & Bull, D. A. (2013). Mesenchymal stem cell population isolated from the subepithelial layer of umbilical cord tissue. Cell Transplantation, 22(3), 513–9
176. Chen, G., Yue, A., Ruan, Z., Yin, Y., Wang, R., Ren, Y., et al. (2014). Monitoring the biology stability of human umbilical cordderived mesenchymal stem cells during long-term culture in serumfree medium. Cell Tissue Bank.
177. Gao, W., Zhang, H., Chang, G., Xie, Z., Wang, H., Ma, L., et al. (2014). Decreased intracellular pH induced by cariporide differentially contributes to human umbilical cord-derived mesenchymal stem cells differentiation. Cellular Physiology and Biochemistry, 33(1), 185–94
178. Hendijani, F., Sadeghi-Aliabadi, H., & Haghjooy Javanmard, S. (2014). Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord andWharton’s jelly matrix. Cell and Tissue Banking. doi:10.1007/s10561-014-9425-1
179. Pan, H., Lan, J., Luo, X., Gao, J., Xie, X., & Guo, H. (2014). Biologic properties of gadolinium diethylenetriaminepentaacetic acid-labeled and PKH26-labeled human umbilical cord mesenchymal stromal cells. Cytotherapy, 16(1), 74–83
180. Lindenmair, A., Nurnberger, S., Stadler, G., Meinl, A., Hackl, C., Eibl, J., et al. (2014). Intact human amniotic membrane differentiated towards the chondrogenic lineage. Cell and Tissue Banking, 15(2), 213–25
181. Mennan, C., Wright, K., Bhattacharjee, A., Balain, B., Richardson, J., & Roberts, S. (2013). Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord. Biomed Research International, 2013, 916136
182. Santos, J. M., Barcia, R. N., Simoes, S. I., Gaspar, M. M., Calado, S., Agua-Doce, A., et al. (2013). The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX(R)) in the treatment of inflammatory arthritis. Journal of Translational Medicine, 11, 18
183. Trivanovic, D., Kocic, J., Mojsilovic, S., Krstic, A., Ilic, V., Djordjevic, I. O., et al. (2013). Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton’s jelly. Srpski Arhiv za Celokupno Lekarstvo, 141(3–4), 178–86
184. Ramis, J. M., Rubert, M., Vondrasek, J., Gaya, A., Lyngstadaas, S. P., & Monjo, M. (2012). Effect of enamel matrix derivative and of proline-rich synthetic peptides on the differentiation of human mesenchymal stem cells toward the osteogenic lineage. Tissue Engineering Part A, 18(11–12), 1253–63
185. Guan, F., Ma, S., Shi, X., Ma, X., Chi, L., Liang, S., et al. (2014). Biocompatibility of nano-hydroxyapatite/Mg-Zn-Ca alloy composite scaffolds to human umbilical cord mesenchymal stem cells from Wharton’s jelly in vitro. Science China. Life Sciences, 57(2), 181–7
186. Majore, I., Moretti, P., Stahl, F., Hass, R., & Kasper, C. (2011). Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Reviews, 7(1), 17–31
187. Struys, T., Moreels, M., Martens, W., Donders, R., Wolfs, E., & Lambrichts, I. (2011). Ultrastructural and immunocytochemical analysis of multilineage differentiated human dental pulp- and umbilical cord-derived mesenchymal stem cells. Cells, Tissues, Organs, 193(6), 366–78
188. Witkowska-Zimny, M., Walenko, K., Walkiewicz, A. E., Pojda, Z., Przybylski, J., & Lewandowska-Szumiel, M. (2012). Effect of substrate stiffness on differentiation of umbilical cord stem cells. Acta Biochimica Polonica, 59(2), 261–4
189. Karadas, O., Yucel, D., Kenar, H., Torun Kose, G., & Hasirci, V. (2012). Collagen scaffolds with in situ-grown calciumphosphate for osteogenic differentiation of Wharton’s jelly and menstrual blood stem cells. Journal of Tissue Engineering and Regenerative Medicine, 8(7), 534–45
190. Detsch, R., Alles, S., Hum, J., Westenberger, P., Sieker, F., Heusinger, D., et al. (2014). Osteogenic differentiation of umbilical cord and adipose derived stem cells onto highly porous 45S5 Bioglass -based scaffolds. J Biomed Mater Res A.
191. Qian, H., Zhang, X., Xu, W., Zhu, W., Cao, H., Chen, Y., et al. (2010). Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotency. Biotechnology and Applied Biochemistry, 55(1), 53–62.